Defining the prevalence of cardiovascular disease risk - the role of screening tests

Ioana DINUŢ

Emergency Clinical Hospital "Saint Andrew the Apostle", Constanta

Ana Maria Patricia MICU

Faculty of Medicine, "Ovidius" University of Constanta, Emergency Clinical Hospital "Saint Andrew the Apostle", Constanta

Iulia TUCĂ

Emergency Clinical Hospital "Saint Andrew the Apostle", Constanta

Bianca RADU

Emergency Clinical Hospital "Saint Andrew the Apostle", Constanta

Prof. univ. dr. Elena ŞAPTE

Faculty of Medicine, "Ovidius" University of Constanta

ABSTRACT

Introduction: Cardiovascular diseases (CVD) remain the leading cause of morbidity and mortality worldwide, and risk stratification and early detection are essential components of effective prevention and management. The role of screening tests in defining prevalence and identifying high-risk patients is crucial for the implementation of early interventions. This study aims to evaluate the impact of various screening tests, including biomarkers and...